Corporate GovernanceAug 11, 2026, 04:13 PM
AnaptysBio Stockholders Approve Directors, Auditor, Equity Plan
AI Summary
AnaptysBio, Inc. held its 2026 Annual Meeting of Stockholders on August 11, 2026, where several key proposals were adopted. Stockholders elected Hollings Renton and John P. Schmid as Class III directors for three-year terms. The appointment of KPMG LLP as the independent auditor for fiscal year 2027 was ratified, and the non-binding advisory approval of executive compensation was passed. Additionally, an amendment to the Company's 2017 Equity Incentive Plan was approved.
Key Highlights
- Hollings Renton elected Class III director with 15,304,522 shares For.
- John P. Schmid elected Class III director with 20,314,669 shares For.
- KPMG LLP ratified as independent auditor with 22,343,352 shares For.
- Non-binding executive compensation approved with 21,274,791 shares For.
- Amendment to 2017 Equity Incentive Plan approved with 15,563,882 shares For.
Price Impact
More from ANAB